Evidence map›Paper›PMID 38995007›Full record

ArticleCells2024

A Short Sequence Targets Transmembrane Proteins to Primary Cilia.

Viviana Macarelli, Edward C Harding, David C Gershlick, Florian T Merkle

Abstract read
In one paragraph

Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Viviana MacarelliInstitute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0002-5875-8290
Edward C HardingInstitute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0002-5803-2780
David C GershlickCambridge Institute for Medical Research, University of Cambridge, Cambridge CB2 0XY, UK.ORCID 0000-0002-0602-210X
Florian T MerkleInstitute of Metabolic Science, University of Cambridge, Cambridge CB2 0QQ, UK.ORCID 0000-0002-8513-2998

Funding

Wellcome TrustWellcome Trust and Royal Society 211221/Z/18/Z
6 · The paper itself

Abstract

Primary cilia are finger-like sensory organelles that extend from the bodies of most cell types and have a distinct lipid and protein composition from the plasma membrane. This partitioning is maintained by a diffusion barrier that restricts the entry of non-ciliary proteins, and allows the selective entry of proteins harboring a ciliary targeting sequence (CTS). However, CTSs are not stereotyped and previously reported sequences are insufficient to drive efficient ciliary localisation across diverse cell types. Here, we describe a short peptide sequence that efficiently targets transmembrane proteins to primary cilia in all tested cell types, including human neurons. We generate human-induced pluripotent stem cell (hiPSC) lines stably expressing a transmembrane construct bearing an extracellular HaloTag and intracellular fluorescent protein, which enables the bright, specific labeling of primary cilia in neurons and other cell types to facilitate studies of cilia in health and disease. We demonstrate the utility of this resource by developing an image analysis pipeline for the automated measurement of primary cilia to detect changes in their length associated with altered signaling or disease state.

Indexed as

CiliaInduced Pluripotent Stem CellsMembrane ProteinsAmino Acid SequenceAnimalsCell LineHumansNeuronsProtein TransportMembrane ProteinsiPSCpluripotentprimary ciliaprotein traffickingtargeting sequence

Identifiers

PMID38995007
PMCPMC11240719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.